- Rice-Based Infant Formulas, developed as dairy-free alternatives, are becoming increasingly vital in infant nutrition, especially for babies with lactose intolerance, milk allergies, or digestive sensitivities. These formulas offer gentle, hypoallergenic nutrition and are gaining traction in both developed and developing markets due to rising health awareness and demand for plant-based options.
- The escalating demand for Rice-Based Infant Formulas is primarily fueled by growing parental concern for infant health, increasing prevalence of cow milk protein allergy (CMPA), and a rising trend toward clean-label and vegan-friendly nutritional products.
- China dominates the Rice-Based Infant Formula market with the largest revenue share of 41.21% in 2024, driven by a large infant population, rising disposable incomes, increasing consumer preference for premium infant nutrition products, and strong distribution networks.
- India is expected to be the fastest-growing region in the Rice-Based Infant Formula market during the forecast period due to increasing urbanization, growing middle-class population, and expanding awareness about food allergies and digestive health in infants.
- The Standard Rice-Based Formula segment is expected to dominate the market with a market share of 43.2% in 2024, owing to its widespread availability, cost-effectiveness, and suitability for general dietary needs among infants who cannot consume traditional milk-based formulas.
